Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

CCS-NG

Class 5Status: Objected
Application Number5697471
Trademark Status
Objected
Trademark Class5
Application Date2022-11-25
Proprietor NameINFINICTUM LIFESCIENCES PRIVATE LIMITED.
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameLAW PROTECTOR[14326]
Agent AddressDhumal Nivas, Behind Kamla Nehru Hospital, Near Barane School, 104, Mangalwar peth, Pune - 411 011
Goods And Services Details[CLASS : 5] PHARMACEUTICALS, MEDICAL AND VETERINARY PREPARATIONS

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
CCS-NG5Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about CCS NG.

What is the status of trademark application 5697471?
The current status of trademark application 5697471 for CCS-NG is Objected.
What is the trademark class of CCS-NG?
CCS-NG is registered under trademark class 5.
Who is the proprietor of CCS-NG?
The proprietor of CCS-NG is INFINICTUM LIFESCIENCES PRIVATE LIMITED..
When was trademark application 5697471 filed?
Trademark application 5697471 for CCS-NG was filed on 2022-11-25.